Content-Type: text/html

#

    Reference sequence (query): batch____
    Identities normalised by aligned length.
    Colored by: property

    HSP processing: ranked
    Search cycle: 3

                                                                                                          1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .         .         .         :         .         .         .     ] 286
        batch____                                              bits   E-value  N 100.0%   1:286             MIHQQHMRNIAQWLQENGITRATVAPDWMSIPCGFMACDAQRVICRIDECRGWSAGLALAPVMFRAQLNEQDLPLSLTVVGIAPEKLSAWAGADAERLTVTALPAITTYGEPEGNLLTGPWQPRVSYRKQWARWRVMILPILLILVALAVERGVTLWSVSEQVAQSRTQAEEQFLTLFPEQKRIVNLRSQVTMALKKYRPQADDTRLLAELSAIASTLKSASLSDIEMRGFTFDQKRQILHLQLRAANFASFDKLRSVLATDYVVQQDALQKEGDAVSGGVTLRRK
      1 UniRef50_Q089T9        General secretion pathway p...   220     6e-56  1  19.3%   2:286 113:401     -VAHEQMQIWLEWLHHAGLKVKRIVPDCLALPLEQCRWAasEYLIRTSEGSGVSMPKAWSAFALPKLLIAanDNESISVASYSDDIVFEGVDINNKPLDLPMMVLAKGILNAPINLLSGIYKPKHEYSKQLLTWKNAAIVVMIAIVLALANKGIAIHQLNNQTTELQAQSEMIFKQAVPGVNRIVNMRSQMGSELRSMQGQGGGAVFFEMLDGLKPAFS--KVPELKPNTLRYEANRNELRMQVTAKTYGQIDTFKELVSKDYLLEGGAMNSSEESVTSTLTLRNK
      2 UniRef50_D0I3A2        General secretion pathway p...   207     4e-52  1  26.9%   1:286 109:399     VIEHKIMQRWMDALSDANLTVRRLVPDCLCLPLHEDSCSahRWLLRFGETEGGSVEDAWLPVWLQSLGQSRGEETLPTVFSYSPLPEGMGGNWQAEPCELVMLLLTQEAVKSRYNLLTGRYKPQSQIYKYLKPWRGAAIAAGLLVAVLGIEQVVNIYQMDAQAAQYRTQSEARVRALLPQNQRIPtmRRIVEAEVNRLSGAGSQSGIMVWMAEIGPLLDAA--PSIELDALRFDQNRDELRLNARGKDFGDFEKLREALSTTYNTELGQLSRDGQAVTGAFVLRRK
      3 UniRef50_A1SR64        General secretion pathway p...   203     7e-51  1  19.9%   1:286 112:403     ICDKQKMYDWIDWLEKAQINCKQFIPEGLTLPLPEDgwlGEQWLIRETANIAWSCDHSMLNTILEslKNSADEDLVPRIESYSPVIEDSVAEWSSHDAMLPMELLAIGTKNNPVNFLTAEFKPVKEVSPYIKKWRIPAAAGVLLFIVSVLNIYSHTLQVQAETELIQQQVETIYSQAFPRESKLRYARikLDTMLKELQGSSVEFDFLTVLDDLSPAL--MSLKEFEISSLKFDSKKQELQLALTAPSFQAFETFAAELPEHLSAQQGALNNSKSGVSGVLTIRKK
      4 UniRef50_A6FGY7        Hypothetical general secret...   201     2e-50  1  20.6%   1:286 112:404     VIAHDKMQQWQTWLADAELVCEQYIPDALTLPYNEAHWSagQWLIRQTPTQGLCIESELLTFVLAtyPEDEGVNNIPTVMSYSPLDALALDNWQQGQIELPMKLCAEGAIASRYNLLQGQYKVVREENVALKLWRGTAIAASLAMVMIFVNQFVTLNKLEQQQSALDNEIRQVYKTVFKPKKMRLnvKKQMQSRLNDLRGGGDNSGFLVMLSQLTPAFKQL--PGIKPISVRYDTKQATIRLQASAADFQVFDKLKSSLSTQFDVAQGTLSQRDGRVQGTLDIKGK
      5 UniRef50_C9P1R4        General secretion pathway p...   201     3e-50  1  24.6%   2:286 117:408     -VDRAWLQAMLEQLQALGLDVKRVVPDVLALPVHEEGLSadQWLVRKGEYSGLSVDKDWLTWFCAswVKNQTEYLPLTAYTPLPepLSEQQSWQSMACPSLLVLLTEQVLTHKINLLTGPFKPKSSWNKYWLIWRKAVIAGLFLLVVLMTSYGLQVHKDTQLAQSYRDESERIFREIFPDKQRIPtlRRQMTDELTALSGSAQGEDVLSWFSRLPETI--GSVTDMQVQSLRFDGNRSEVRLDVTSSDFQSFEQARVKLAEYFLVEQGQLSRNEQRVSGSFVLKPK
      6 UniRef50_Q5E1Y5        General secretion pathway p...   200     5e-50  1  23.4%   1:286 112:417     IIEHSKMTMWLEQLSDAGIQTKRFMPDVLALPFHDDGAsgQQWLIRHHEYQGAVAEPQWVSMLleSDEDAESSPMPFILHSYSeeMEIAGAKVNLESPELVMQLLAEGLLSSKVNVLNGPYRPQSSWRKHWRVWQKVILSLGLVMVAFVAQHVSEVQKLEQHSLALHAESERIFRDIFPNKRKIPTakSQMKNEEARLQGGAGGHDLLAWMAEISPYLS--KVPQVKLQSLKFDGKRNEIRLQASASDFPYFEKLTSELGTKFEVEQGQLNKNDGQVFGAIIIRRQ
      7 UniRef50_P45782        General secretion pathway p...   196     8e-49  1  19.6%   2:286 117:407     -VDRLWLRACLDHLKACGFDVKRVLPDVLAIPRPEHGllGDEWLVRKSTTQGMAVDAQWLSLLAAswVQNEGEYLPLQALTPLPesLAETQEWRYEPSGLVMQLLTQEALTSKFNLLTGSFKLKSSWLRYWQIWRKVAIAAGLFVAVSISYSLFQAHQYEAQADAYRAESERIFRSIFPDKQKIPtlKRQMSDEMARLSGGASVGSVLKWLSPLPEALKGV---NLQLQSIKFDSNRSEIRLEATSRDFQSFEQARTQLEQYFAVEQGQLNKNGEQVFGVFVVKPK
      8 UniRef50_Q47VE2        General secretion pathway p...   191     2e-47  1  17.8%   1:286 119:421     IVAHSQMQQWLSWLADADIETDTILPDVLAMPIVAEGWSaeQVIVRQKLWQGFNVDANAWQLQCqaEGNEQSHSILIEAYSPLAHSEQCNVSTMPEELALALMATNYDSKLSHFNLLQGQYKVKENRSHTGRQWLWVAGVAMFAILLSLGHKSAQLWQLNAEQENIQQNIVASYKKAFPKTkrISTIKSQLNRELALLGGVGDRQGFLAMLAKLQPAFA--KVPALKPESLKFDGKRQELRIQATAKDYQAFEQFSVALatNLIVKQGSQSNQGDQVTGSFSITNK
      9 UniRef50_P31708        General secretion pathway p...   190     6e-47  1  17.1%   1:286 134:424     VVEKNRMQRWLAQCDALGLSVDTLLPDARVLPKHQDGWSALqwLFRQPTGHAMAAESSWCGDLLKASMPLPAIYSYSAASVGGELAQYEwgEWKAQPETDLFTLAATAHLPASVDLRQGDYAPDKAWQNTLLPWRGVGIAFACYLLLVVADAGWAHYQLYQQAEHWRQESVRVYRQIFPSETNVVNPRAQMQQHLQRTAAGGAGKALLDQLTPLQQLMTQ--NSAIKIQSLSYDGAAGEFRLALQGTSYQELEQFQQQAAAYYQVQAGEMRQENDRVEGRLTLRSQ
     10 UniRef50_B4S158        General secretion pathway p...   188     2e-46  1  18.6%   1:285 111:397     IVSHEKMLQWQAWLSEAGLFCDTIIPDVLAVPATPNGWsgEQLLVRQDEFKGVQGEQAWLLPTLVHFTAQQEAPVTITNYAGIDLSSLPNIEEAQAPLELPMQVLAKEAMQSSFNLCQGEYKLKRKRSGVLSQWRVAAVLAVLALCTSLIDKGVTLYQLKSENQALSSEINAAVKAGFPNIGTYRNVRLKLQSELAKLEQGGGDASMLIMLDQLAPAFTATD---VKPQTLRFDASRTEIRIQAQGKNFEALEQFKRSAeaGFLVEQGAINNRDNGVVGTVSVRS-
     11 UniRef50_Q5QY99        Type II secretory pathway, ...   180     4e-44  1  23.9%   1:284 113:398     VVAKERMNYWLQVLTEAGIDSAFWVPDCFLLPHQNDTwlADSVIVRTGEWQGFTIEKEQFAQLAPAFAAEQNSPTEIIHYGAL-NWPQSPAPLIPADIEVPFTIAVQSIagNRINLRQGAYRSQRAKRSVDLPWKGLATAASVLFVLAVLLNGVRYWQLESQRGALKAQAEQLYRDAFPGQTRIVNLKVQLQRQLESLggSADEASVLAVLQQLAPAFK--SQPELQLELLRFQNN--ELRLQATASSFSQFEAFQQAaaEGLTVEAGSMSNRGEQVSGSLTVQ--
     12 UniRef50_C4L990        General secretion pathway p...   179     1e-43  1  22.5%   2:286 113:394     -VEQTQMQQWLSWLADAGLTAQQLLPDVLALPQPEGEqlGDQWLIRQSAWQGSVVDNDLFSAWM------TCHQPYPALHSYTPPPAEPPAEWIVSLCELPMQLLAEQVPVQRIDLLQGAFRRVSTWKKQWLRWRLPAVLTGLLLLLFMANQGMEYVQLRQQQQQLQQQMTALYRQLFPEEKRIVNPRAQLKQHLQGLQQAPLTDSFLSQLALLAPLL--HKTPEIELQQLRFEADKQEFRLQISAKDFGMLDKFRNQANTTFATEMTNMQDQGGRVSGMLIIRSK
     13 UniRef50_D0Z0Q1        General secretion pathway p...   179     1e-43  1  23.9%   1:285 116:435     VVEHSKMAYWLEQFKQHHFEVRKLLPDSLCLPLFNDGYSaqQWLIRQSETLGINVEISWLDAWLSAqaAQDEDLSQVIIHHYTPAPEVQLGRWRAETPELVMQLLAQGAESSKLNLLSGAYKPQAAWRKHLLPWRKVAIAAGLVLTALVAEHVIAVNQMENQAQAYRTESERIFRQVLPQFKRisYLRNQMKRAVASM-GGEQQQGLLTWLLELQPMLKQ--VSQMQFTNFKYDQKRGELRIQANSTDFQHFEKLRTLLAKDFTVEQGQLSKEDGRVNGAFVLRR-
     14 UniRef50_Q46833        Putative general secretion ...   178     2e-43  1 100.0%   1:286   1:286     MIHQQHMRNIAQWLQENGITRATVAPDWMSIPCGFMACDAQRVICRIDECRGWSAGLALAPVMFRAQLNEQDLPLSLTVVGIAPEKLSAWAGADAERLTVTALPAITTYGEPEGNLLTGPWQPRVSYRKQWARWRVMILPILLILVALAVERGVTLWSVSEQVAQSRTQAEEQFLTLFPEQKRIVNLRSQVTMALKKYRPQADDTRLLAELSAIASTLKSASLSDIEMRGFTFDQKRQILHLQLRAANFASFDKLRSVLATDYVVQQDALQKEGDAVSGGVTLRRK
     15 UniRef50_C9NLJ3        General secretion pathway p...   176     6e-43  1  18.3%   2:285 113:403     -IDYSWLESILADMRQLGFAVRKVLPDALALPVAEEseLDGQWLVKKGQFSAVSIELAWLPLLAQswVKQEEEYLPLQAYSHLPEllADEQKWHNEQPQLVMQLLSEQAVKSKLNLLSGEFKPKSSFGRHLKVWRKAAIAAGVLVAILSVDNWLQIQSAETQANAYRQESERIFRQVTSKnpTVTYLKREMEREESRLSGGGSGDSVLEWMVKMPQVMKQ--VPGLRLTSFKYDSTRGEVRLQAQSNDFQTFEKARELMSGQFTVEQGQLSKSGTLVNGTFVLKR-
     16 UniRef50_C4K3G0        Putative uncharacterized pr...   174     2e-42  1  19.6%   1:286 112:407     VIAHSYIQTCLDWLAHAGLQATRMIPDWLALPYQEGEITanDWLFREGTYQGFTLEQECLPILyqDQTRDSTLNQNIRSFSSPPEDSSFF--WQAGAVIPALTVLARGCLSPNITLLSGPYRQNRTIRMPLLKGAAAVCMAILCFvlSVIEKGLIFHRLTQEIKKTQIKAEQAYQALFLKPQKVVNLKAQFNALTNQMKSQPKVPHLMDFLAQIAIGIANMRIQPRDMhaLRYAREHHSLYLQIGVNHFSEFEQLRNGLSEKFTVEQGVLVQEKKRVNSTFTLKNK
     17 UniRef50_A0YG41        General secretion pathway p...   173     8e-42  1  16.5%   1:284 127:422     IVSKKILERIIFELKSDGIEADQLESELHAIPIDAGSWsdRRWLVRSGNHEGFSLQPTIAGQALEILLESNDELPQHlvLSIIPERLQSAIDWKIANYWQVMSKGHTNHQKNAINLLQGQFAAKLPWKKWWQSWRTVAVLLIAVVIIQMGVRYTQLVVLDDRNIALRAAIEKQYRQAVP-KGALMDPERQLRRKVNALKGSAS-SNLMSMLVQIGPVLKATD--GISLQSLNYNEKQSEFRITILASGFDDVETVRANLEngLTAELTGSNADGNSTRARLRIR--
     18 UniRef50_Q3ILN2        Putative general secretion ...   172     1e-41  1  18.0%   1:284 116:399     MTDREWFEAWLALFAEHNLSVYKILPDALLLPPADEdaLNNQWLFKQGPWRISAVETSWLNGYLTAMGN----PDVKHFSPATQFPETVNLQAQTSDYDLPLALFAKQLEHTKFNLRQGMYQLKKKSTLWWGYWKSAAIITSVALVASITIKAIELHQLNTQLELAKAQVIERYQKAFPGTkrPHLIKNQIKGALAKIQDTSD-AGFLELTTELVGVFSQ--VSNFTPETLRYDKKRNELRMRARAKDFQTFGKVKAILeqGLTVDQGSLSNDGDFVVGEIKLR--
     19 UniRef50_P45789        General secretion pathway p...   170     5e-41  1  23.6%   2:276 119:388     -VDKEKMQIWLGWLQQAGLKSQQLLPDVLALPPAADGWSALqwLLRQGPCQGIVADESLLAML----LAAEADPVTIHSHTPLPAIPAA--NWLAADPELPMLLLAKGALNCQANLLQGPYRPQTEYSRYWLQWRKVAVVAGLLLLVALTQRGMHLYQLAEQDKALKAEIRQVYTRIFPGENRIVNVRSQMAQHLKLLGQTP-QDGVLLLLTELAPTFA--EVPGLKPQVLRFDAARGELRLQVTAPGFAEIERFRELAGKRFEVQQGEGAQHRGQ----------
     20 UniRef50_UPI0000E10DE5 general secretion pathway p...   170     6e-41  1  18.0%   1:284 111:410     IVAHHTMRQWLDWLTTANLHCDIMLPDVLALPLAPVTAVedQVLLRDSAWSGFCGESDWVIPVVSSYFNAQSGPISLTQYTTDDAFSSHqvQTVTAELELPMHVLADGIATHSFnlCQGQYQQRKRSSGQWQYWRSVAAVAVIALTLGLIDKGLTISQLAAQNETLSNQIKADIQSGFPNIGTYRDARRAITQYVKRIDNMGSGSSAVDMLANLTSAFA---NSEIKAQSLKFNDDRSELRIQAQAKAFSDLETFKQQaaAGYTVEDGAINNRNNLVIGTLTIK--
     21 UniRef50_P15751        General secretion pathway p...   169     9e-41  1  15.9%   1:283 116:393     VVGRGKMRAWQAWCDSLGLSVLALTPDVLALPHSPTGWSaeQWLFRCDTWGGMAVETVWLDQLLTHWQDLAP----IACYSPPPDIAAP---WQPLPAQDLLQLAAANPDARRICLRQGDFAAKRRRQPTPRRWRPVIVAALALLLLWSSNCLHDHLMLGQQADAAVQASRDFYRQWFQTEKNVVNPRLQMQQHLRQMKNAGARPALISRLGALQQIID--DTPGIRLRTLSFDAARNALQLEISAVSSQALEQFSQRARARFRVQTGEMKPRADGIEGRLTL---
     22 UniRef50_A0YBF0        Type II secretory pathway, ...   166     8e-40  1  18.2%   1:285 117:445     VVSHAVLINWLDILHSVKLSPTRIISDVLCIPFHAGQldDKRVMMRSGQHSGLVLPIEDFGFLFASWIGQHSKQDAVSAKPvePEVVakVTAYHEPIAEILVSSYSNERLDRQLNLLQGGYAVSAAGKNDWSNWRSVISVVAIGLLSYLLLMAGSGWYFNGKGNSLDAEAVLLYQQLFPNERRIVSPKKQMQNHI-RLSGVGKNSDFLPILASLASTLAADSDekLIVDQLRFDGGSGELQIQLRSSSIEKLDQLKRNLEggLEVDINSAAEQDDYVMGRLVVRR-
     23 UniRef50_B7RST7        General secretion pathway p...   164     3e-39  1  16.6%   1:283 107:395     VCSKENMNAYQSSLASYP-GVTQWLPEPLLLPWQGGEweGDRAIVRTGACEGFSVEREMLSLMLHALTLEGAAPTAIIVYGQDQETDAALVdvQWRQGDLYAAMLIAESPDPALNLRQGEWAVRLPLARWWQHWRVAAVLFGVAVLVHLFATGLDYRHLKQENLALRGAVQSSYRQAFP-KGAVVDAEKQLRRQLQTMTGSSEASGFVSLMARVGEVVATAD---GSIVSINYNDKSGEMRLNLLAADYEAVERIRTGIAegLQATLENSSAQGERVRARMRV---
     24 UniRef50_O32574        W0030 n=15 Tax=Escherichia ...   163     5e-39  1  15.5%   7:284   1:276     ------MHRWLAYCGQLGVREVRLLPDVLMLPLATEGWSagQWLFRRDRYAGMTVELSWLTHFL-----SLTAPPVIESYSVPPVpgPKTTEWRNQPGRDLLQLVAEGDGYDGADLRQGEFARQGTWYARFRPWRYVAGALLACVFLAGSNAGLAHYRLWQQAQFWRYESVRVYQQLFPSEKAVKDPRRQMLRHLQQSTGN-NIPELGSVMRQLQQLLS--ETSTIRLQALAWDSSSQTLKIDLQAASFQALEHFQQIAGEKYLIQPGEIRQQPQGVESRLILR--
     25 UniRef50_B8KIY8        General secretion pathway p...   155     2e-36  1  20.5%   1:283 107:395     MVDRASMLRWAEELGELA-SLVPWVPEPLLLPWSPGEwdSDSALLRYGRCLGTRIENALLPTLLETLAQESSPERVieTADLARLGPLGTPGIQWRKGGLAAALLLHDPATPAVNLLQGDFAPQLPYRRWWGQWRRIAALLLVALSIHLVGGWLDLQRLERENRVLRTEIQSVYREVNP-RGAVVDAQKQLLRQLDGLRGGATGTTFTGLLSPLAELFS--PPGSLVLASLSYSQRNAELRVNLLAANFADVESLRVAlaAGYAASLESSSRSGDRVRARLRV---
     26 UniRef50_C4T0X3        General secretion pathway p...   151     3e-35  1  10.6%   2:275  91:359     -VEHKLMNQWLGWLKEANISAKIIMPDVLALPFSLGKFSanEWLIRNSQLSGFSISSEILAKILDSKFSSA----HINTFSSSGN---KAINWQSTQYCDVLRIMAENIDYCNANFLCGKYNHFPGIEMNGLTIFRTVLLCLILSAVVCLNYWFDRYKIARDIDVLNTVSQEFYANIFPVDNENRNNTGHFNDYIEHYRDIESNANFIDLFYMTSPVIDSIDS---NVNSVSFNKDAGVMSYNISADESNTVekLKEINNKLSGVVLNQVSNDSD-----------
     27 UniRef50_Q2SFC4        Type II secretory pathway, ...   149     9e-35  1  13.7%   1:284 117:427     VIRRERMDRWFDAANALEFPLHGMYVDAQMCPGEEGAldGDEVLLFQPGLVCMRTHHENLLPYLerASSEEGEAPAWNIRVLTPEDQKDSLGVLLAQIEHVDGaqIESFSVPSfnLCQGPYAIksSGSSGIGKWWPVAAVAAGWFAIQVGLDLTQGFMYQKQADEYEQQMVKLYRSLYPNEKNVSSPKRQMEGKLRNASNTGGGGFLQLLGEAGYQLSVQPGKQNMGFNNLQFSNQRGELAVEVKAPSLDQLDRYKQALVqgYQVDIGSAIKEPSGVRGKITIK--
     28 UniRef50_C8R0C2        General secretion pathway p...   148     2e-34  1  19.6%   1:285 106:409     VIARERLDYWLELCRQHGLAPAGMVPEMLAVPLAGPDAAGReaLVRTGPQDGFVLDRDSLAImmPGIGNEAKLEFYHEEEAPELPEELAVLLAGSHRVGDVFALLAETleKEALNLLQGDYRPQAHWEKHWRRWRLPGVLVLVLLLFYAGLGLLENQRLSRYHEQLHDEIIEVYRTTFPGAQRIVNPRAQMEHQLQTLRGAGGEsgFLPLLADSGPVLSGA--AGMQLRGLRYRA--GELDLELTISDLQALDELKAALEegLEVDIRTATTRDERVLARLQVRE-
     29 UniRef50_B1JQA6        General secretion pathway p...   146     6e-34  1  10.7%   2:281 120:392     -IEHELINRWLFWLNINGISACCIMPDAFALPFFNSEWseSNWLVRNNEMSGFLVNSSVLENILM------LAEPTIKVNAFSPTDI-KWGNWQSLDYSDPVLIMAKTVSGNHVNLLSGKYKYAERIIVNNSVFLRVASWFFLLFLVMSLNGWYQGYKIVRDTGALSKVAQDFYADFLPPAYHGGDVNTSFNKYISDLDLKKNNVSFIKLLNAVS---YYTADENVDVRSFNFNYSDGEISFDIEGDD-DLINEMLNDKTNLFNARVEVIRSGEDKYNIKL-----
     30 UniRef50_Q5ZUD0        General secretion pathway p...   145     1e-33  1  15.9%   1:283 109:378     VIDKQRMKKLIQVFDEHGIEFDAVTLDWFALASQELIISESELLINNEDFKGV-LSGDLAQTYlpHTPAHLFQDSKIPVASPASQNEEHSYTWISKRL----------IKSKPLNLCQGEIQHGKTTDWVKKGYLLVGGLCGFWLISILFVNWLSLHWLNRQIDEIDRQTAVIYREFFPDAKQVISPKFRISQLLGG-STAENQTRFWFILNQLSKAIKD---SGITVEQLRYQNK--TISITLVSSDFESLQKIENKLKqqLKVKQTQASTKDQQVVATLEL---
     31 UniRef50_C5BM28        General secretion pathway p...   144     2e-33  1  18.9%   6:285 114:406     -----LIAEALEELTAQGLDVRTVAADYLCLRRLNNGVtaNRVVVRTGEYTGFAVETFLAPQVLAEQQTALDFTATISLVAEDETALAELRSWLPEVWTQENGPEISeaQAPSINMRSGAFSRQLPFKRWIELWKIPMIAVAAAYLIAVAITFAQYQVAKQEQRVLVDQMNDVYLQAVPN-GRRGDPEGALRALVKNLKGGAEPTNLMALINGVASTMK--SVAGITVSSFRYNSDQRELTLNIEAGSFEDLERLRSTveKGFVAELLRVEARGDKQSARMKVAE-
     32 UniRef50_Q1N4H6        Type II secretory pathway, ...   142     1e-32  1  15.4%   1:285  82:364     VVNKQYM----DGLFEHQIQHAYYLP--LALPFDKnaVLNDQVLLRLSEFKAYSIQKEAVGLFLQRFKNEFESIQVFGDLDELIKLEMESENIEIHQKTLDDLNQLIQSSRPNHDLMSGPYKVtkKKNPKLDLLKTPLTLAAALFICAISINWIQAFQLDGKSEAVKNASKNYYEQLFPGESAGYGMKRMFRQKLEEGELVQNGETFTRLLSGIGNPISSMS--SLELLGLRYNQSKATLEIELNAPSIAELDKLKKSLEQqyTVEIAAANNQGGKIKGLLKVNK-
     33 UniRef50_A3WP17        Type II secretory pathway, ...   141     2e-32  1  21.9%   1:283 115:398     VVRHSEMQQWQQWLAAAHLEADEWAVDYLMLPEPegVQIADDVLIRMARWDGLAVEQTLADAVVG--LKQSEYPQTNHVVAYSDIALNDSTLALEFANSELPMVAFAN-QRVSLDIRGQRYAPKRAKRTLEIRWQPLAWAAGIALAVTLASSWVKTAYLNHQAEQLQQQAEALYKETFPNQTRIVNLRAQMRQQLQSLgdDQAMPSALAMLDQLAPAFQQQ--PQLSLELLRYQD--GALRMQAVAQNFSQFEAFQNQAQqgFEVQQGALNNRGDGVAGTLTI---
     34 UniRef50_C7R8F2        General secretion pathway p...   139     8e-32  1  12.0%   1:283 113:407     VIDKAYLSSVLERLKEAAIEPDFAVSDAACLPLFEDAWtdDSVLVRQSANEYWSTEVDMLEDLvtQFEENQTVSQAARIYSPDEQSElaGLAIQKMSVDNSLEWLCSQFDNSSINLLQQEFSSQKKSQMNLGQWKLPTIAASVLIGVGIIYMISQMIVLGQQRANLKQQMLVSVQEVFPNINDVNTGLIQVSNRFSTLGGDAASSNSFMLL--FDRSLAAINPKEIKVSQLEYLSSQAQLSFDVEAASYTTLTGAQNKLesGMQVEMRNASENGGVWSARISV---
     35 UniRef50_Q21EQ2        General secretion pathway L...   139     8e-32  1  14.0%   8:286 117:409     -------AGAIASLEEVNCDIQRILPDYLHlpVGAILVLDEGVlcRTSDNDGFAIDESAAPIVVSQLKHEYDFTGVIELVAETEELAEAMKSWLPAKWLDENGPEIRLREgpTFNMRRGRFARQLPIMRWVKDWKVPGYVAAAAFVLAMAAVSLEYFQAKAQFDRVRSEIFAVYKQVAPN-GRSSDPVRAMESMVKGQGGKSEPTNVMMLIDSTAKALK--NTPEVNLTSMRYSGDQKELRVNLETKNFSDLETLRTAIAkgLAAELLRVSAQGEIQQASMSVAEE
     36 UniRef50_A1WZN9        General secretion pathway p...   139     1e-31  1  15.0%   1:286 108:407     VVEHAAMQAWLDEFASLGLEVDALVPENGLLPADSGHwdRNQVVLALGA-DGFALEPASAPVTLEAALAVAERPPQRLTLQAPAaePAPELESRAVDADLLPRLAAWYHPRTAVDLRQGPYARRERWGWLWRPLRPAAALLAVWLLGQGALQWLEVQRLEREAEQLTAEIEQVYRETFP-EGRVVNPRVQMEHHLRTIRGDRGGEGGGHLARLLGKAAPALAGDGLRVRTLRLRD--GSLEVELDTVDIETLEGLRRALeaGLAVEIRSASAREGRVDGRLVIREE
     37 UniRef50_Q31J19        Type II secretion pathway p...   137     5e-31  1  17.0%   1:283 106:365     IVSNERMTQWVDALTSAGLANAQLVPDCFQCPIPEEHntDTHRLARTGKWTGMAIPHDWLTLafKHMTWQQEAPSFQVMEHFKP-----------------------------FGLRQGKYQPFSKSTAWAKNWAKVIGVFGALLVLLVTQNWMEAHQKTIEKQQLTEATERLFKQMFPEVKRIVNLTAQAKTALDQQPSEVAGVGPAQLAKAVEPAFKQ--VPKVEIKAFKWQNKR--LSLSLESPDNDSLQALAGALKNKVTLTLKINSMQPNQIQAEMVI---
     38 UniRef50_Q8GBD8        Yts1L protein n=5 Tax=Yersi...   136     8e-31  1  12.9%   2:273 122:384     -IDKNQLEQWLGWLRSAGLSASRALPDVLALPVPTGGWTAArwLMRQSVDQGFSADDEELGFILGRYPTL----PAILSYSQRPENEPTWLQKNVQPIWP---LLAQGAQKNSINLLHGDFTPPRTAKV--RGNKLLVALAAVYLLTFVTEPTLSGYYAQQHAEQIQQKTQQLYLKNFPGATPPKQWIQGIAQQIHQLEKDITPPGLLSQLRAAMPILQSLT--GVKTQAMEWQSETLALTFNLAEPEL--LARIPRQNANKLNITTHPMDQQ-------------
     39 UniRef50_A1U0C5        General secretion pathway p...   134     4e-30  1  17.0%   2:284 122:433     -IDREQMARWRQLFSGwhARLEAVYPDASLLPAAESGwdAESALLQsgEWLRMQADnpLLAVTLAAPSSDEVVAEIPVQLYGTEADLDASQALVSELSGTTGLLRIEKKpsQPINLCQGAFAFKAEGSSPLKPWKPLIAVASLWFVIQMGLEIGMGIYQQQQAEQLESQAMAVYRNAFPSDRraGNVRRVIEGQLRVAGSQGSDVDFITLMKYTGDQYGRLQNPgvTFNSINYSRSRGELVVDIRADSYDRLSRLRNGLaeGLQAQIGSVVNESSGARGRLTVS--
     40 UniRef50_A4A5K5        General secretion pathway L...   133     7e-30  1  18.4%   1:283 105:393     MVDKQLMHHWETQLDVFARQV-PWIPEPLLLPWSAGEWtaETTLLRYGLQEGTRVENSLLPALLGALRDDAPPERVLvaVGENILAALEDLDLQWRRGGLEEALLLSEDGRSQLNLLQGEFAPQLPYGRWWREWRAIAALLLLALSVHLASGWLDLKRLQRENLVLRQEIETVYRGINP-RGAIVDAEKQLRRQLDGLRGGATGGTFTGLLAPLGAALSPQEDT--VLASLSYSQRNAELRVNLLTANFAEVESLRGSlaAGLSASLESSSRSGDRVRARLRI---
     41 UniRef50_C6XJ55        General secretion pathway L...   133     9e-30  1  14.5%   1:283 108:385     VITNEKMVYWSDTVKRAGLVATKIVPDYFCLPIEDaaNLVDRSVFRYGHWGAcgFDSKLLDKIIASGVSQNDNIAELDQLSYRDF---------SEGGVDPLDVLAVQAVKEKFSLQQGQfaRNLGGKLDLKEWRLPVGLAAAAILAMAAFNFVEGIAFNREAKALQATIEADVKRVFPDVKRIVNPKAQ----LKTLTSGNGEASAFLQLSGLIST-GINDVDGISLDALRYDARRREIQASIVYEDYEQLTQFREIIEngGTFREGGSRQIGNRRAGEITV---
     42 UniRef50_B8GU52        General secretion pathway p...   133     9e-30  1  18.2%   1:285 108:409     VVSRAQMDQWREQLREAGLDPRSLVPETALLPTHGEGweHDSAWLSTGPGEGMALDRDNAALLVRLRLEETDEEARPGHLEVVRHGPARDTdwRDSEATLLEEIAQQLPAKLPFNLLTGPYSRREQLGRLWRPWRAAAAVLAAWALIQVALVVVDIQRLERERAALDAQMREIYETAVPGSRAGGDPRRQMESALAGRGREAGAAGAGDLGEALAHTATVLtlSGLSIQSLRYRPGQMELDLQL--DSLQSLDRLKQELEAdwAVEIQSASARDDGVESRIQIRR-
     43 UniRef50_A1JPG7        General secretion pathway p...   132     1e-29  1  12.4%   2:259 120:371     -VEHELMSRWLGWLTNVGVSPTVMIPDVLALPFNDGRclDDEWLIRNSEVSGFSVNDDIFKKLCLSTLIFCPENRFSRVYNQT-------SGLHATDYCDVLRIMANNIENNHVNLLTGRYYRHRKKTISSASFFRSVYLFFLLSIVMCLNSWCYKNDILRDIHMLD-VTLQGFHIKYPLVQQYADEDSivNKDFYHSDGNIIKPDLIFLLHGLVENFDRLD---ITIKSIIFTNEKNKSSFNVRVINVDGIDQVLNKI---------------------------
     44 UniRef50_A0Z782        Type II secretory pathway, ...   131     2e-29  1  12.8%   3:283 101:384     --SQADMGSWLESLGDD--FEGAFVHEALFLPWQPGEveTRSVLLRWGQHQGARVEHDLLAPLLNALPTAADAVIVYGRdaLLPDVLRELAQWRQGHFGT--ALMLVDRGQKFIDMRQGAFAPSLPFKRWWQSWKPLAIALIIGAVLQVASDLAQYWRLKDDNIALRAAIEESYRQANP-RGSLVDAEKQLDRQIAEYAVGVKGLIFTEILDRVGRVIAVSS--ELTLSSINYSDSAGEVRLDLLAPNYDEIEALRErtTSGLNATLETSSQRDTQVRARLKV---
     45 UniRef50_B3PF10        General secretion pathway p...   129     7e-29  1  14.4%   2:286 116:424     -TDKNWLHMVFAELASLGLEITRCWSAPMTLPlaPDQAIAEHWTlrHNAYQGFSASSSYAPLALQLLLneSSDLPALHLRAASEAELDSLRGLLPSMLQGQIASqaLDFGTNTIDLCQADFSQRLPVERWWKLWKSVAIFAGVCLLVYFSTALFEIRKLGKENLAIRQDIEAAARLAIPQ-GRIVDAEKQLTGLLRQMEPAQASGSVMTLLAKTLPQIAALS--SVQIKGVAYSSETGELNINIQADSFSTFETLSSNiaQGLAAELLSANVQGNVQTARLKVSKQ
     46 UniRef50_A8AIN0        Putative uncharacterized pr...   129     8e-29  1  15.1%   2:273 108:369     -IDATCFERWLALCEEAGLKVIQVLPDAILLPVNEGGStdESWWLRFPPFGACEADATLLPLLLA-----QGGDGEVCCYGEAPAGIDVVEQLPWQHPLVLIQP---QWKACRANMLHGAFAACGKEVGRFRHLRTAMAVSALlmGLLIGPRVAMAWMLVQQENQVQAEIAQVAQHYFPSLRQKTNIKYHFGQNIKKQSKG-----IFLQLEALEQVKQ--SVPAIEINEVEYDNAQNVLTLNAASPNAQALQDFVTQASPHFDFALQPVSNQ-------------
     47 UniRef50_C4RZJ2        General secretion pathway p...   128     2e-28  1  11.4%   2:246  91:329     -VEHSLIKVWLGWLQNAGIYTEIIMPDVLILPFNPGEwlGNEWLIRDHEFSGFSIQEAVLKKLVLSRFISISKDLFSTSNDKP-------IDHHLVSYCDVLRIMSENIENCSANFLRGKYAFCHNQGSKSNYNFKFIWLLFLLSTLICSDYLIENYKIGKSIDALTFMSDDFHNDFFWNNKVGTTEIIDFSYYTYSYNRRVMNFNLISLLHDSSHIINDLD---LSINSIYLDNERQTISFNVTT----------------------------------------
     48 UniRef50_B8KQM0        General secretion pathway p...   128     2e-28  1  17.4%  20:283 142:410     -------------------RLRRWLPEPLLLPWQAGEWteDSVLLRIAEYQGTRIEYELLPALLRALPPPESGLIAyrALQAIPDELRAMVQWRQGGFGD--ALLVADIGPATLNLRQGRYAPRLPLQRWWGEWRWVAMAAGAALLLQLGSDLVIGQRLKHENQALRAAIESSYRQANP-RGAMVDAEKQLDRQLAEFQSSDVSGAFTPTLAAITSVLAQET--GITLANLSFSGRQGQVRVNLLAPDFSAVERLRSAMSqgYQTTLESSSAAETRVRARLRI---
     49 UniRef50_A4VFT8        General secretion pathway p...   127     4e-28  1  19.9%   2:283  38:308     -IRRQLLAGWLEQLRELGLLIVAIHVDADLLPRE-----ATQLLFIGERGLLGGEGETRLAFATVDWPQLATLCPAPWHAQGNVAEPPLALDDYRQLDDPYAFLAAQ--RSAALNLAQGDFAVEVG-NTGLGYWKPLFAVAGLILLVQLGFNLGQAWYFQRQGDAYAEASLALYRELFPEDIRIVNMRAQFDDHLAR--GSGGQAGFLRLLDHAAAALEDGIP--VTIGQLDYNQDRGDLALQVQAMDFATLETLRRRLgaRQSVQLGSASREGDGVSARVVI---
     50 UniRef50_P45763        Probable general secretion ...   127     6e-28  1  15.8%   2:285 112:384     -IQSEKLSRYLERLHTAGLNVTRVLPDGCYLPWEVDSWtqTSWLIRSAAHAFNELDEHWLQHLAAQFP-----PENMLCYGVVPHGVAAANPLIQHPEIPSLSLYSADIAFQRYDMLHGIFRKQKTVSKSGKWlrLAVSCLVLAILSFVGSRSIALWHTLKIEDQLQQQQQETWQRYFPQIKRTHNFRFYFKQQLAQQYPEAVPL-------LYHLQTLLLEHPELQLMEANYSQKQKSLTLKMSAKSEANIDRFCELTQSWLPME----KTEKDPVSGVWTVRN-
     51 UniRef50_C4U9B7        General secretion pathway p...   126     7e-28  1  11.1%   1:280 107:371     IVEHELMELWLYLLRTNGVIIESLIPDVLILPFINGEWSaeEWIVRNNEVSGFLVSDELFEKIYSFWYSSTLVNIMNDCD-------VKNVNWRVIRNKDPLHFMAKDIQSCNSSLLTGKYKFHDGAGITHRYISRVTGWGVLLSLIICLNTWHDGYKIAQATDMLDVYSNFYYSQ-FP----IVN-------ESGDLSRNESSVDFINLLSYLLGYFDDKD---LDIVSFHFSKEDKAIFFDVDRIDPsdFPEWAGNENEKIKISQSYNESGKDRVIFK------
     52 UniRef50_C6P583        General secretion pathway L...   126     1e-27  1  13.8%   2:284 107:397     -VNKDWLSRFLAASTAARIRVRRIVPEFCLLPTRTnaWDGAQGFLATADHLGGMLDseVRAPAALQLRLQQGAPAALRLFALGSEIRQPDWGIKVPVikQSFDWRKADIPADAPNLLWGKFAPPPRISELWPWLRPALMAALLLFGVEVAVSNVEWAMLAHEKRQLMNGMTETFRETFGADAVIVDAPLQMRRNVARLrgVGDDADFSPLLEKLSGVLDA--VPGSTLRTLRY--GEGKLDIEMALASASALDTLLQRIAagLTAQVLDKRDSGGVLNIQLRIS--
     53 UniRef50_A3YCA7        General secretion pathway p...   125     2e-27  1  15.0%   1:286 124:429     IVDKQVMASWLdwLQVIVLPVNSLIPFWPEQDTEADFLFTSDLNLLYKDQDSVSCLPKQGANYLPKREkdQAEVDGFGALAASFEILSPWSNQSVnwLYIVATRVQSNSKCLLANLCHGEFGRQTQFFSQLKPWLWVGVFAVFSLAVELYLTHQQTQALNAKADDIYQKTSTAFLKLAPDEGRISYLDRQIKGRIQRaqGDAKTQKGLTVYEVMALVDQVREQVSGEHRITKFDFANKEYRLDWQAGQRDTLDSIQTALEKkfQVVFEQVAKRGEVYVASIKLKEE
     54 UniRef50_C4UYF5        General secretion pathway p...   118     2e-25  1  11.4%   2:255  99:344     -VEHKFMQLWLGWLKDAGISTTVIIPDVLTLPFSNGQWTsnEYLIRNNYFSGFLVKDTIVEKLLLTKSHLLSEDVFICTNSQPE-------NLQRGQSCDALRIMANNVNDSDVNLLCGRYYRYRKRVADNYFSFTRISILLLLFVVVFINSLFNKYEIENDINIL-NELSRGFYAKFPSVE-------QYDSYSQNDNGYpdRYNFIMYLHDSNTAMVNINSA---INSIRFDNKNRTlnLDITNSNVTdfDQI-------------------------------
     55 UniRef50_P25060        General secretion pathway p...   117     4e-25  1  19.5%   2:283 108:380     -VQRTWLAAWLALAEGAGKAPASLHVDADCLPGEGScwLEERWLLGGSGAVRLACGSEDWPVLRDSCPPPQRAFAAQEVAPLEGVEVQAL--AGNPHVWLSEQPL-------GTDLAQAEFA-ARQQSSQWRRWRPLLGLVGLWLVLQWGFTLVQAWQLQREGDRYAAQSAELYRQLFPEDRKLINLRAQFDQHLADSASSGGEGQLLGLLGQAATVIGGE--PTVSVEQLDFSAARGDVALQVRAPGFDVLERLRSRLSegLAVQLGSASRDGSTVSARLVI---
     56 UniRef50_B5JVC6        General secretion pathway p...   116     7e-25  1  14.8%   1:284 103:396     VCERRLMDAVVASLIEANLPVDALRTDVQALPMPQEAalREDDVCLHGAHGSVHCTRAELPIFLQQLYREQSDDehLSVFHAAGDVPDWPVFVEIDQQETVEEllLSRGAASGVNLLQGEFVIKSQSSGSLQRWQVPAVLAVVVLLVWLGSMFYQAYQYKQENQRLRDDIIAMYQSVAPGAQvvMTVKRQMQNRLDRLEQGGdtDASLKRLNRLASALQDQDLTQGLS---RVSLNRDALDFELVAENLESIETLRQALEqgAQADILSAPSQDGEVRAELRMK--
     57 UniRef50_B2VI00        General secretion pathway p...   114     4e-24  1  14.7%   2:286 108:354     -VDPPRLQAALDAVKQRGFTPDYALPDVLMLPHGQAFRLDEQWLARTEPFSGVSVAVADLPLLAAQDSALCERVKEH---------------------ETCGRLTAEAEKISLPSLLHGGFSPAVNWRNGLRSLTAALFLSGCCLS---AIPLYHGWQLNLAADRFREQTLQHYQHYFPQE-RPAKPAQALLAHIHQKETHKPTAGLLVLLTECSALLS--NIKEIPLQTLEWDAKRQQLSL--------HFAKVIPADNELITPEGYQLARQGD---SSIIISRK
     58 UniRef50_Q0A612        General secretion pathway p...   113     5e-24  1  24.5%   1:286 110:422     VIDRERMATWLHWAAEQGLELHTITPLELAIGAGDDDWrdQAGWLSTGPRAGLALEADAWPLILPRLLAqaPAGLALHPAGAAPGQVEALRAALPDTLTVSEQPAADSppHQAINLLQGPFSGREQWLRRLRPWRAVAALALAWVGLQFVMLYAEVRNLERTEQALRAETVEIFRDTFPD-SRVVNPRVQMERALAELdpERRSDPFIAVLNAVAPALTGDDAP--RLRSLAFRQQR--LELDLDAASVQALERLREAVEArwQVQIHSAASRGERIAGRVTIQRE
     59 UniRef50_A8GJP7        General secretion pathway L...   111     2e-23  1  13.6%   3:274 113:356     --RHVDMQRWLSQLERWGIVPDSLLPDTLCGPVNDRHFYRWrlLRRTSPWSGYSLPSQWLL------------------------APSDVVDAVPLSPCDVLWDRVRGEAETAVSLLQGKYKAPPRWQRnwRHWPSIAGAALTLCALAIGGA-----HYHHQAKQANQQRDALYQRLFVGQPIPAEPVSESARYIRALQEAKSPRQFFELAAQAQRALQG--IPKHRVIGLTFDADRSMLAIRLQAPELQPFTQI-NDEGNTLELQVNPAKQQG------------
     60 UniRef50_B8FE40        Fimbrial assembly family pr...   111     3e-23  1  10.1%  50:286 233:476     -------------------------------------------------CAGAGMNWENLQDAVQEQTGLPLKEINLTRDLQLPMEGRVAGNWDSSAMDGALALAlhPTETTGFNMRQGPFAVRRRWEQYKGWVIHVSILLAILLAAFGVRYFANKSVQEAKIASLKSQIEEVYQSAMEGRASSGDPLAAMMSEMEALSQapGAEGANVQVVDVLKAISDGIPPALNVKITSFSVNPERVEINGETDAYESATEIKTGLERQpdVSLQSVTAGKDPGVWKFRIKAQ
     61 UniRef50_Q2Y7T3        General secretion pathway L...   111     3e-23  1  15.6%   2:283  91:401     -VDKKRLTQCLDALQAAAIQVDEIYCETLLLPWTPgaWEGREGFVRTGEFEGGATdpLSLHLMLEDAERHGARPASIALYTIEPEGAMTFEESAGEIMKNPAAApwRGAQQSSISLLQ-KHRRWPPFRGLLSRLRPAVWIGAAALVLHSLAVAADWALLANEERALHQQMETRFRALFPAAVAVVDPALQMRRKlrHAAGVPDTADFLPMIKTVGPALS--ELASGSLHAISYDSGRIALEL---AAEEGLANRIAARleNDLSVDINPAPTDGGAGIVVLVV---
     62 UniRef50_A3UEX0        Hypothetical general secret...   111     3e-23  1  15.5%   2:284 113:426     -VDRDQLKTWREMLASLDAPQHHTVPDGMVLTGHGGDLtgDRVVfrSGDLGALSDSQDGARDLDAALSDPVCGAIEPHLLTppEGKPIAVKRIDAPDLRIAAASLPPEALDALPAIFGDAFATKLDWAALLKPWRAAAVLGLTAVLAASGLMVGQAAYLQDRASRYQAAQEAEFRMLFP-EARIVNVSAQMRQALNSVSGGasGAGFLPLATVLSETLS--DVDGVRVDSLRYDASRGELSVTALYSGFGDFERLRMAAEARGAveDGGARQSAAGVAGEFIVR--
     63 UniRef50_B7GZW5        General secretion pathway p...   111     4e-23  1  17.3%   2:284  97:374     -VAQGMVETWQHSLALLPTKLVALLPDFLVLPEPQAqnIDHQLLVRENKWLGNSIDD--LGLFLEFQSAETHYQYSGLTAEQLESLEAASSAEQRSEFVYQFQPLDKTKQHP-FNVLP---KSKGQERTFSNYWKACAAVVLAIIVVQFSYDLLRWVKLKKVADQTAEQAIEQYKYWFGPSSRVtnIKGQFESHLRMSQQG--DTQALSLLSRVGPILMQR---QILAQQLNYDAS--ILTMALKAKSADDLQALTQQLnqGFKAELGNVQADGSGAIGVVKIQ--
     64 UniRef50_Q3KBD9        Putative general secretion ...   110     5e-23  1  16.7%  11:261 113:346     ----------LQHLGQFGLNLKGLYPAAYSLPVMSGglHDDHLLLRHGQSSA-----QVQPMIDEAWLLETGLPAHWIGDGAPEAVQSTLADTQ-----------RCSGPLPNWGLHGGIQQPGTEHRG----WGRALGCCALALAVWVIGLNLYAAREAGQGQQLKAQMAQRVKQAFPELPVILNPLQQARQQIAARQQGAVDAPGQDFTRLVSQAGSGMPSMAGTVQRLEFVDGALQLSLLPEARRSGNDKGWQDTLAQ-------------------------
     65 UniRef50_D2TMH0        Putative T2SS protein L n=1...   106     1e-21  1  15.8%   2:286 109:374     -VEPAVMQTLMLPLTAGGIRPDHVTLDALCLPITTDGwdEEGWLLKPHEGRASRLSEEWLDHLLTHY-----RPQQITSYGELPEAHTADTSCSPRP------LLSLYSPTESVNLLHGRLRPSAPATAGIRRLKRLALIAVLMLLLCPLLsaIVGFQLHRLEQQLTSTLEQRWRSYIPQNRHRGNLQAYLPKQLQQRFPAPS-----ILLQRLGQGMAA--FPALALEGIRYDQQRQSLQLFIYASDEDQIKQFITADAVGLPLKIEKHDQ------GLWTLRNE
     66 UniRef50_Q0C119        General secretion pathway p...   106     1e-21  1  14.1%   1:283 102:363     VVDRSLMKSWIDLLTKAGLAPEKILSecLFTDIDHPVNLGDRIIQREG-NRIVGIDAALPQQARDALSAPTLEP-------------------SLEDGLHLIRLAERSTTRPAVNLRTGPFTLTKSAKQGVSAWRKAAGIAIAAASVWTGTLILEARNYNHAKEVTEKRAAERYTALFPVAAIPTNMD-QATREMLAVAATPDTLDFRTSVAALYEAVAQSTNTQIT--ALKFEGTDNRLTVDLSSPSPEALGAIISFLqrGFQVTSPEPVAGDESSTTQIIL---
     67 UniRef50_Q0VPY1        General secretion pathway p...   104     3e-21  1  17.8%  37:283 120:375     ------------------------------------RWAAEQDVLITSLQVDAERLQGQAPLIAELDENqaDRDRCLVVDAQQRDGVQALFGDSLNEPMVLSGPTaaLRNGSGQELLTGPYAPKQKKGSNtaPWKPLGILAASVFVLALVAIWVQQWRYNQAAEATFADAQTLFENLFPGDKASAALSRQFEGRLARLGGgsGQADFFPLLRPVAQVLKEI---NVDPKRLQYDQRENTLLLDVGAKDYAQLEQLQNAlkQGARASIANYRNSAQGVSARIKV---
     68 UniRef50_Q1YQU7        General secretion pathway p...   102     1e-20  1  17.9%   1:285  88:364     VISKQDMREWLRIADNAGVTATAMVPDYLALPFESgaWCEGQFLVRSDTDSGFSAAPdlVRRLLERADIAPRLSISILDAALMPEDLREAADVNDAEIDWQFSDMPMSA-----NLLTDEFKPQTT-EVSASSWLSTAALLVLAIVLGFGYLQLSNVRFEERIAELETQASAGFSNLfgKRAKPDDIRSSGELLMADMFKQRESLQA-PVMKALIASDPIMTNCNCELETLVASDSGVSLGLKNVASG-----KIKATTVPGFKVDQKVA----DGVT-TLTLRK-
     69 UniRef50_A5GC15        General secretion pathway p...   102     1e-20  1  15.5%  66:284 224:437     -----------------------------------------------------------------ASADQETSPFPPLPVNGEFAEAFAGDTNSARDLAGAYAVARAIATGDPVNFRSGELAYTAGQAKTRKKLRLSMILAVSFVILLFAEVGLRYYLVKKDVDSLNNSIKTIYREVFPTRKKAVDEVAELRSEIKRLSSGKTSSNLLPILTKLAEAKGDDV-----FEVFEAEISGNQVHLKGDARSIQAVNDFKTRTADALsvEVGEIKSRPDG-SVSFVLR--
     70 UniRef50_Q2LVK0        General secretory pathway p...   102     1e-20  1  12.9%  51:283 267:505     --------------------------------------------------TGGGALSATLREDLEKFFKTPVEVVDLLKMKGIPLPGKNRLSWNAPLMNQALALALRGGNGsgFNFNKTEKAVTNARNGMKSQLRWTALMAVILFFALGSNLAAGYYADSRKLRHLKEETTKTFKNCCPEVTRIVDPVRQLQQKIIEARgsRGAEQGSLFLDSWKKAMDTLpaSGIVIRELSYN--QIVLEISGEASDFQAVTRWKGELEknIQMQFGSGTNKDAKKTFKLRM---
     71 UniRef50_C0QLU1        Putative general secretion ...   102     2e-20  1  15.3% 107:283 286:475     ----------------------------------------------------------------------------------------------------------QNTSQPVLNFCRERYAEDSILKRHARNIAILLVFTTMAFSAFMFKLHDDIHGLEKKGALLDGASVALFKRNFPQKGRIVDPLMQMKIELEQLKQAPGLGSMENSVAAAPQliSNRIPATIDVETTRFILNPGRILLSGSTANFNDIDKIKGLLekQVEIQSAAADKTGNRVRFKFMI---
     72 UniRef50_Q4KD22        General secretion pathway p...   102     2e-20  1  13.2%   4:268 122:378     ---RERLQALGRLLEQAGLKLAGLYPAPYALPAPPPglLDEQLLVRQSATQGSV--QPLVAETLEQLRASASELCWIGEVPALPGQPLP-------APQPLAAQLRWSGTPPSWGLHSGALAGTRAPQG----WGRALGCCALAVAVWVLGLNLYAAREAEQGQRLKAQMSQRVKQVFPELPVVLNPLQQARQQLAARQSGAAADPSQGFAHLLAQAGLAMPFMVGSVQSLEFSGQRLQLQLLPDTPKTADSAWQGALIQAGYSVQAQ------------------
     73 UniRef50_B3E7L3        General secretion pathway p...   101     3e-20  1  16.1%   3:276 120:422     --AQGQIADLITTLTEAGAEPEIVTASCllLPPDSSecRQGQLLfrTLNNNSDDLERTLATLELTRDLqlASTSERVIELFPLPDALKTPASQDGLAPLALAAPFAAALAFcpFNLRSGPLAWKQKNRRLLRAFRLPLILACIAAVLLLAEAGTRWYLLSRDITSLNSSIGKIYRESFPNRKKAVDEAAELKAEIRRLEGTSLSPTILPFLRLLTEH-KGVEISGFS--EIDYDGTRFKVKGDGRTS--AAISTLRqlLTAGWQVEQPEITSRPDG----------
     74 UniRef50_B8GXS1        Type II secretion pathway p...   101     3e-20  1  14.0%   2:286 110:367     -TARDKLQAWLDMAQTHGLAPQAVIPDYLLLPEAEDGV--------------------LTVGRLGARLALREPSKALSADADLAALLFENREHRYLAGKELDAQLITGARAPVINLLQGRFAVRTTGGRGG--LRRLAILTAAAVLSPLLLMIAQIAHDQWTARALERQATKLAVSLAPQASRYEDA---VGYALSRLAASQSGQGFGDLSASYLSMVE--STPGVTLDTLVY-GEEGAIRSTIVYNNYSDMDQLRLGAKrgLELTEQSTASEGGRISSDLIIRRK
     75 UniRef50_A6V157        General secretion pathway p...   101     4e-20  1  17.0%   2:284 103:358     -VRRDWLRERLARLAARHLRPKHIHVDVDCLPG----------------------DPPLALRCAGRWLVSAGSAQRLALDDAGLEDLGPVLPPGLRRSEAPPWPLLAEGARLAIDLRQGEFAAHTAKRI---RWPLLALLAVLAGAAQMGQDIGHRLLLEQRSAELRQDNLALWQQRFPSEGRVVDLTRQVQARLRQ--DGQSPVDLARRLDRLADTWSAGGGATATVRRLDYQAGEG-WSLEVGAPAFADLERLREGLaqGLDVQADSAVRGHDGVSARLQIK--
     76 UniRef50_B7RHZ6        Putative uncharacterized pr...   101     4e-20  1  13.8%   1:283 125:395     VVDRNVMQA----AAVAGDTP--VLPEIFALPTPATaiSDGRALVRVSDGTGFVVSVAMLPLIWAQAAKPQ-----IQSYGEALPDTMDARAYDARPPKP-------DPKDLGVDLRQGAFAPKAT--DWTRHIKRAAIIAMIGVIGHLGLIVVDTVALTRIAERERAAAQAAIDTVLPGLIVTADVEPILRR-LAPAAPAPKGSAFLTILGNVSAALLEADN-QISFRRLAFADNPARLTMSVEVPGLDDLQQAERLLRagFVVTSGAATASGGVAEAEFVV---
     77 UniRef50_A3VSK9        Putative uncharacterized pr...   101     4e-20  1  14.2%  11:278 118:380     ----------LAYLRELELGPTAITVDHLAIAGEDArlFSETATVAYLSDGAFTVPAEMGADLLALMPLAANADVTAAGGHPPKGGGADRSLPDRDA--LAAYWFGKVMAHRPPNALRGRFRRRTDWRGVGKRVRMPVALSLGVIALWLGGVAIEGMKYQRVADQLYDEAAARFSEAFP-----ATPIRDLSRQASRLGGGATTDRFLPLSSRLAAALESHD--EVQLEGLRY-GQDGELVADLRFPNTAALEQVREDLRTGGIteGETIRREADGSS--------
     78 UniRef50_Q7NRH5        Probable general secretion ...    99     2e-19  1  14.6%   7:286 106:388     ------LRRAVAMLKSLGRLCDRIVPecLLSPPPAGGWssDRWLVRAAAPYAASLpqQEQALFASLLSTAMPARLQLCGVDSAEEVLARLPGWQGETARGEACDWRSARRHGGYDFAQGDLAANRYWRDWAPSLKKTGWLLGGLLAAQILLTLGQSGWYAWQKHSLSQQIRAAATPWIGGQAQPGSSALAMTRAVDRLRL-SHGLPARDDLVELMGALAAVSGRELQVRTLEYEAGR--LKLQVAEVPAESLARWRKQLAARQIMLDATSSQPGSK---QLVVARE
     79 UniRef50_D0XKE4        General secretion pathway L...    99     2e-19  1  12.4%   1:283  94:371     VVRHARIQGWIALLTEADLDPAILMPDALTLPMPPQgvEGGRCLVRTDTGAGFALPLSALDGAWTA----AGRPRLIPLGDALPATFAEAVGSETLHLGTMGEPV---VVLPPLDLRQGPYA--ATRATSASALRTLALVAGVGVVAHIALLGLDTFLLDRMADRKEAEARTVLQAVAPATTPDEDIVAAADRIVP--GAGSGVRPFTRLLAQTSGALPGAGAVAFN----SATYAPGSLDMGVVVSDAATLDRAVQALTASGLTASGaaSSATNGLNATLKV---
     80 UniRef50_D0KWL6        Type II secretory pathway c...    98     2e-19  1  15.2%   2:283 116:411     -VDADVRTRVLDALKDQGLVPQHLVAMADTLPQPEMGEfqEHISVLTGPHEGMALApeQLAEWLPRMTPAPNRVAFHVPLDQPAHWPEGIEFTAQAAPDWAQWHQLWQAGLEQNRALSAITSAKAVNDQQwrRWWQVAAAAGVVLVLLLVAQGIKTAQMNHQAERLQTQITQDFHAALPQITRMVNVRVQLQQALDQ-RVGAHEDTFMPALAAFGSAYQVAKPQDAQLVIKSIRFGEQQLTVELTAQKYAVLQQLLEHLKKNAPAEVKQIDAGVDAGVAHMRI---
     81 UniRef50_C6BGG8        General secretion pathway L...    98     3e-19  1  16.3%  15:284 206:475     --------------AVAGVTPATIALDA-APSSDPDAPVAVDITVRTGRAEGYGL--RLLPANVGNWLGIAPAPATLMVSPALREllSADPATATLDWSTWAAGARDALASGEADLCQFDFARGGVAGMDWSLWRLPIALAVLIVVVQLIGMNARWLTLRAEQKRLDTAMRAQLQTAFPNTPVILDPPAQMRRQVEQLrgKSAPEDFLPLADRFAQAATGLAPDA--LLALDYHGRALTVTLK-DGTDTASLRTAARNVGLNMDTAEAPRGAEATVPGSRWTVS--
     82 UniRef50_Q48JN5        General secretion pathway p...    97     8e-19  1  14.1%   7:261 114:353     ------LERLSRLLSQSRLSLRGLYPAPYGLPVPAPglRDEHWLLRHSAGQGGV------------HPRLTETPDAHLANGSELHRLDDKGTAGLETS----AGLLLSGPSPGWSLHAGIGAAKVRTSGWTAAW----VCCGLAVGVWALGLNLYAAREAARGQQLRAGMVQRVSQAFPHLPVILNPLQQARQQVAALESGSATGTNSGFEQLVKSAAGALPFLVGSVQRLTYSDGRLQLQLLPDNAQPAVDDTLQRSLAQ-------------------------
     83 UniRef50_A3W190        Putative uncharacterized pr...    96     1e-18  1  17.3%   1:283  95:391     ITDAGDRRDWLRALGVFAPQCRAVLPDFLCLPAAPDLwtATGVIARLGPEDGFAAEPDLALALLQEAAR-TGMPRAILRNGPARAEIDTFLTAQNLPIcgVTAPARFAYNELSLDLARDPGAERAEMRGILSRLGLPFALAVLGLAGWIAAAMIETGTLTAQGLAYRQNAERILRQVMIPTGPILDIRSQVAQTMDRARNARSEVETEArlDVLRRAGAVLGNHETTITRVRYQPGAG-LVIDLQITDFAALDALVADLraGTEARVAqiTRENTGVDAVLAM---
     84 UniRef50_C5CPK6        General secretion pathway L...    94     4e-18  1  11.7%   2:248 113:372     -CNRIWLRTLVQGLESAGRRVVRIVPEFAPQPADggEAEAPQLTVCDADGVVSLPLAGAGLALAAGLPLDTAVISAEPAVAQAAEHLLERRVPIVQAPQRWLQAARSPWELAQFDLagKKFASVVQTLRYAPEWRAARWGIVALLLTQLIGLNAWAWKERNALEAKRQAVKTMLTRTFPSVKLVVDAPLQMAREVAALQQAVGDVAGSD-LEPMIGALAPHLPPGRTPSAIDYSAGQLRLRGLGLQPS--------------------------------------
     85 UniRef50_Q5P1A1        General secretion pathway p...    94     5e-18  1  14.7%   1:286 110:402     VISRARLRTVLAGLAEVGCPPLRAVAELQAVPDAGSRWttGGCILRLDATHAFVADAGALADILAHALLQapEALEVRRAPTAPGSIEPATLAGTVPGLRVEAGAawETPAASADLLHGEFAPSHRGSAGRQALRRPLILAAVAVGVFAAVNLASVLWQRHELDGIEERMRRLFVTAVPDTPAIA-PALQLRRHLDEARSLRGELREDDLLALLSAYTegGSAAPASVRTLDYEAGQLKLTLDAASASG------IGVLEKRF-ASLGYVVRSTGGAAPSLTLSRK
     86 UniRef50_Q1NDR4        General secretion pathway L...    90     7e-17  1  12.8%   3:284 116:371     --SRSDMQHWMLWAQNHGLDPDIIVPAPLLIEAPE---------------------QGLGRAMIGGAAVLRGENMALPEDMALPELIADAPMIDVTTGMVEGR-AIAALDRPPLDMRQGDFAKRVRPALDHRALQRIAVWTGMILFLLLATALIWLARQHSEANRLDRESLALAQEVLPNASDAAQAQIEMEGRLAAR--GAGGRAFTAPVAALLSAMQ--DAPGVALTTLSRDAD-GMVRATLASAKAEDINIVLLAlaAGFTITATSSQDPGGRTLAEITVR--
     87 UniRef50_C1TK51        Putative uncharacterized pr...    90     8e-17  1  10.9%  18:284 107:383     -----------------GLGRSTIWPLPFAMAAELGGNGAVLCLDEEGISSALFVDGVPVLYRWQSRSRRSVDQELRWLLDYGGkdPSDSVVVDVSEDGERLAVKARETLTAFPSL--GSYSLSRksAIVLETLAKAVGGFSCWFlvFLGAGFLGGLVERKKVDTIRARAEAVYTDAF-GPGKVRDPLSQARGKLAELTDSPDTRSLEDGLRLIVRSWTDPEMGgiSVDTLRYTSDGMELI--GTAEEVSSVQAFQKNlnNDGTVKLGDIQqpGGGLRYSLEVR--
     88 UniRef50_B3R7W9        GENERAL SECRETORY PATHWAY L...    90     8e-17  1   9.2%  37:275 227:462     ------------------------------------GTRQWQLTVRTGAHAGYGLL--LGDDALAAWQALAPEGNWYaaDATALAPVPALRQAGRAGWPLWIDGAQACLREPGLDLAQFEFAQGRADRWNLVAWRLPLALAAGLVLVQLIGMNTHWLLLRNEQQRLEAAQAQTLRGAFPQTPTVIDAPLQMRRQVEQLrgRSTPDDFLPLADRFAQAARRLPPDA--LQALEYRGRMLVVTLKPGTDTAGLRSAARQ---AGLQMEEDKAGNAAG-----------
     89 UniRef50_B9NIA3        Predicted protein n=3 Tax=c...    90     9e-17  1  10.8%  19:258 634:880     ------------------LAQSALLLDTAA-PAPGELSRLWQLTVRTGPYEGyaLSTWQLLAPAGQWHGDNAALANAPVPALQGKRPPMHASRASETWRIWLAGIEECLQQPQLDLAQFEFAQGRMDRWNVRAWRWPALLVVALLLVQIVGMNVQWLTLRKEAKRLEAAQVDLLHTAFPNVPPVAEPILLMRRQVEQLRTASgpNDFLPLADGFARA--ARDLPPDALLQLEYRAATLYVTLKPGTNTSALQNAVRQA----------------------------
     90 UniRef50_Q1JVU7        Fimbrial assembly n=1 Tax=D...    89     2e-16  1  18.9% 100:284 262:453     ---------------------------------------------------------------------------------------------------LPVCAMALATDQPLINFRRGPFTLKSEWAALKKHFYIGGGLLLASLAILAATALHSYQFKTEVAQDYRKQLNQVFRETLPGQTAIVDPVQQLTVELNRLRETGRLVGLDKSTSALarDFSTHTPKDITVDIKTFNYEPENLNVEGVTDSFDSVNRLAGELRKsvRIADAKMGIQGKQVSFRLQIS--
     91 UniRef50_A7BVH2        General secretion pathway p...    88     3e-16  1  19.0%   1:153 108:274     VIAHAKMDAALQQLSAVGITPTILLPDILAVPKPEEGwlNDIVLVRTGLQAGFAIESDCLSLALQKALIEHEEMPPLEMVVypLAELQALGIPIIEQigTLAWLAQGVTENKPLNLIQNDYLPQDKILTHLRPWRLTIGLLIFWVDCSLLNNG-------------------------------------------------------------------------------------------------------------------------------------
     92 UniRef50_A1WNN8        General secretion pathway L...    88     3e-16  1  14.5%   1:275 119:406     VCDRDWLRENLQALEAAGRRVARVVPEFAPGPTASAgeDAYLVLSGQGADQGVAVLPLSRMALALAQTGSAADQTPVLRAEPAVAALAERTLGQSAGLYT-ASQRALDAARSHWDLAQFDLASSGSRRAMRkrWRAARWGAGLLALTQLAGLNVWAWHERQTLAAKQAAVHAVLTQTFAQVQVVANAPVQMENELARLRQAAGSVSASD-LEPMLAAADAALPAGRLPTAIEYSPGALRLRGLALVPDEAS------ALSGRLQAAGYQASVEDG-----------
     93 UniRef50_A9BXP6        General secretion pathway L...    88     3e-16  1  15.1%   2:260 132:409     -CNKAWLHAHLQALESAGRPVGRIVPECPPQATpaVGSPESAWLLATGLSTAAQGMDSLACLPLRTDSADPAMLAALLQaqADPALARAAEALQRPVSLLTDAQRGLAARAQSWDLAQFDLDLGGGSRTRRrqWKAARWGAVLALLAQVVGINAWAWTENRAIAAKQVQVRSTLATSFPRVPVIVDAPVQMQREVATLRQTAgqGDLEPLLAAASRALPAGQLPQAM------DYQDRQLRLKGVSLEAEALEQAQQHLA--------------------------
     94 UniRef50_A6VAT3        Probable type II secretion ...    88     4e-16  1  12.6%   3:279 114:378     --EASALAPLEQALQRLRLDVRQVQAAPFLLPLREDGWVA-------GEWDGHLLLRRSLTDAAVHPLPEQGLDELPEDLryWLGERPTWNCATLARTEALDEALRWSGPACPWGLA----LKQPMAGAGRGTWKLPLTCAALALLVWVAGLNLYAGRLAGQGQALQRQGIQRVQQAFPELPVVLDPLRQArrRDAYLAGKADGDAAPGLAALLHGTGEAMPFLAGRLQRLDYRDGELDLAL-LPGPAITDAATWQGELGKHGL--QADASDRGWQVRA-------
     95 UniRef50_B1Y326        General secretion pathway L...    88     5e-16  1  13.8%   1:269 118:409     VTDRAWLAIQIELIERTGRAVDRVIcdVQTLASGVGEAGNELAGVTFSSAEGVAcdTQTRPGGLATALLPSPLPAELRCSASPAFVLATEAWLGRPVAVRSQAQRLLAAAHGGWNLRQFDLAPRHRGATLLraWRPARWGLVGLLAAQLIGLNAWAWMQRSELQERRTAMTNLMRSTHPQVRAILDAPLQMQRE-NEALRAAAGRAGDTDLEPMLQAAASAWPDNLAVQTLRYENAQ--LSLGATQLGAEQIERLRSSLqaGWRVEGGA-----------------
     96 UniRef50_C4SKM6        General secretion pathway p...    87     6e-16  1  13.2%   2:145  74:211     -VEHELMSCWLKWLDNAGISISLMIPDVLTLPFSEDKCsdSQWLIRNGEYSGFSIKESIFDKilVKDKNLSTNRVNYISEQQKKAHLINF--------CDALSIMAENINKDGVNFLSGKYSRYRERKSG---FFPPLGLLALVF---------------------------------------------------------------------------------------------------------------------------------------------
     97 UniRef50_A3ERG6        Putative uncharacterized pr...    87     7e-16  1  12.0%   4:286 132:441     ---RRWLENALSVLAVYGLEPKYILPESfaLPRTNEFLSAPSgtLRNGntDASVCMDLLVASVLMDSTEEAFFWTHPEAARPPGAPVIKSPDPEKQEEERYAAALGRWSARAgpDFRNESLAFRKDRDDLVRHIRTLGGVAFLLLLLSLSDAWIHVRALEARVEKTQAILTDLASQIL-RPAPVVEPLSQLTTRKNELAKQEEILSRGTDIIAILKDIAGGPDPGIPFSMVSLSIGKKSLTLSGKTASFQDVEKIRTALLKTPHIRSLVVQ------SARLDIDRK
     98 UniRef50_C6CIM8        Type II secretory pathway c...    87     8e-16  1  15.8%   2:285 116:389     -CSCAWLSAVWDEVQAAGLNVKQILPEWLSLPDAPiaWAEPRWLLRFSKGAGY----WLPAVSVQTLLPHIAAPESVSLYGPPPV---EAVCWAAQHPALSDAQRLAPPERVEVNLLRG--LPGSLHITHIRSWHRYIAAASLGLLAAAILALASGLGMVG----YQIQRDTAFLQAFYAHQSIGDAGAslERLIHDRQQqsGESNFFDRLADYLPLSQRFHDPVIT--RLQFDASQRQLRIDVLLPE-TEVRNLIHTAPANVSVAVHEAQAE--KIHVTLVIRR-
     99 UniRef50_A4BDW8        Putative uncharacterized pr...    87     8e-16  1  15.8%  55:282 179:411     ------------------------------------------------------AEQQQLPDDARIKLISESAEGSAKALATEFEATGYVVNWQVQPTrlVDWHDQAEQRQPIGNLMTGPFS-QNQGRPNYQQWLPALVASVAVIALWTTLTVFENQRTAEKIDQTWQASEDVFLQVFGQNKRIQRpvREMRTRVATAGSGASeaNALTILRDISNV-----PESFMLEDFRYNADRSEAFFTldGDAYSQFEALKNTLAQQGYQVEYSANQESDRFRAQFK----
    100 UniRef50_Q0ASQ5        General secretion pathway L...    86     1e-15  1  11.7%   2:284 111:404     -VETGLLDEWREALAPLIVRPAFIVPDSLVAAEPGAALtgDAILFAHDPDaaGVMDTALFGSVVQALVKAAGS-GEIAVSRSLGLTGANFRAIGQGGIDLRASALDAERLAALPRLFGDSFASTMDWSSLVRPLRRPLLLAAGLLLAFCLLIGGETIYYRLQAERFETATLAEFDHAMPDFGRAveAERLLRARVERLSGD-GQSAFLQLITALDELVDGND--SVRIDHVRYDPARAALSVGATYSDFSDFDDLNARADqgLRLDDGGARESTAGIEGEFVMR--
    101 UniRef50_B2T7P7        General secretion pathway p...    86     2e-15  1  14.3%  41:285 229:473     ----------------------------------------ELAIARGVQGEGLAVPASAVNATLSALAGAAPVSLHMLTEVpaPNSPARLAAYIHGASPLPFEQLARRALECRFDLCQFEFapWRLDRATLRRLRLPVLLAVGALLVAIIGANAQWLMLARQRDAINTQMTELLLNTFPKTTVVLDAPDQMSRQLQQLRVAAgpDDFLPLADGLARSLPPVPVNGIA--ALDYHDRRLDVNFKPEIKLDPDF--AKRLARNGLSGAIDSNT-------GKWTIRN-
    102 UniRef50_C7HZE9        General secretion pathway L...    86     2e-15  1  15.4%   2:242 110:364     -VQKAALQQAIADLAQAGQEPEKIVPEAALLAPGDALLqgPRLLWRDLQGEAAWLPLILAADAAAPQALPLPVTPEHLWVQDQAQPQLSWLDLPPgpATLSDAGWMARAAQSPWNLRQFDLAPKHALSRGwpAWRRVGALLGLLAVVQLVGMNAAAFKLSRQESQLRQKLDTTAAEALPGVPAILDARLQVQRALNDARLRTGRPGDGDLDVLMGRA-SVVVPPGIVPTVLKFSPGQLQLSL--------------------------------------------
    103 UniRef50_C3K8J6        Putative type II secretion ...    85     2e-15  1  12.7%  11:261 114:324     ----------LTRLAQLPLKLRGLYPAPYALPVGAAALDEGYLLTRDSLQQGAV----------------------------------HPLGLQALDVPLVEATQRWGGPVPAWGLHG------RLNQPSTGGWGRALACVALATAIWTVGLNLYAARQVEEGQRLKASMSQQVRQAFPELPVVLNPLQQARQQLAARQTGAAADPGQRFASLVQLAGNNLPFMVGSVDNLSFEQGRLHVELLADSRNPKAEGEWQAALAQ-------------------------
    104 UniRef50_C8PZS0        Putative uncharacterized pr...    85     2e-15  1  14.9%   5:272 114:396     ----ADIHSWINAASLAGIEIVALLPDFLLLPTIDTRidADTQLLKLHTYHGMAV--SFLPLVLTKLPMLETLYLTGFHDETVAQQLASMPNLSIESSELLPTP-IKDPVRHFFN-----FATIKGKTTLAPYAKVIALITVCALLTAFVVDALRWYYYNQAQKQAATLLAQQYAQWFPNEPLSSKLTLQRQLSGKLTTQQSATPSVLQTLSSIQPVLQQY---QLTAKQLNFQNNH--LQLQLLSSSADSLNKAVNDmnKGIKAKLGSVDA--------------
    105 UniRef50_A8ZWZ1        Fimbrial assembly family pr...    85     3e-15  1  12.8%   2:283 134:482     -VHKEKVKEWIDGFAGAGLQPEMIVpeALLVETTGGYVtdAQWIRFFSAgaGRSALRDGLRQTLLAYEYETGVAAGLKNVFVTGADSRAGEawEPGLLDMALCplLKKSRKPCINFRKGEFSLAARWLQYRYLFGGTAALAALVLVLGLMGFFYDLYSLNRSIATVDARRQAIFRECFPESAAAPSAEM-MRYEIDRLRESSGLPAGLDRtvDILNDISRLVPQETDVVITRLDAGLNDVSVTGNTDAFQSVDTMKNRLEetVVISSATMDKADKRVHFKLQV---
    106 UniRef50_Q1QBS4        Putative uncharacterized pr...    84     5e-15  1  15.7%   3:283 108:419     --AQTDIELWQQSAKLAGMNIVALLPDFLLLPLPEEGadKETVLLRQSLYQGMAV--SYLPLIFERFPHLSEVLIVPAIDDptDNELANRTEIENSIAAGSFTAITanAERHALNFF-----VKSMDSQLSPYLRVAMMVALSALVLQMATDAVQWYQYNEATTATKTEIATQYQSWFPNEPLSTRTKLQVQLEPKLRSDSQAPASHMAVLSRISPLIKQSSLKAQALVM-----QPSALSFTLIAPDRGSLDQFTATlaQGLTAKLEQVnnEQGQFSGQVTV---
    107 UniRef50_Q1LHW5        General secretion pathway L...    83     9e-15  1  10.8%  19:258 225:471     ------------------LAQSALLLDTAA-PAPGELSRLWQLTVRTGPYEGyaLSTWQLLAPAGQWHGDNAALANAPVPALQGKRPPMHASRASETWRIWLAGIEECLQQPQLDLAQFEFAQGRMDRWNVRAWRWPALLVVALLLVQIVGMNVQWLTLRKEAKRLEAAQVDLLHTAFPNVPPVAEPILLMRRQVEQLRTASgpNDFLPLADGFARA--ARDLPPDALLQLEYRAATLYVTLKPGTNTSALQNAVRQA----------------------------
    108 UniRef50_B4RFJ5        Type II secretion system pr...    83     2e-14  1  14.5%   2:283 113:372     -VARSRMQGWLDLARLHGISPDVVAPDCLLLPEPEgaARIGGALAVRGRRLAFACDPDLAPVLLQDRDPE-----------------------LASDAEAVERLLAQGAGRPAINLLQGEFAPADGRRIAPRDLRRAGVLAALLLASPMALEGAEALRLSFAADRAEAAARQDAAAVLPKGTVVRDPAAQVAARLERLELAAGGGPAGLAARLFAAL---SGIEGAQVESLIVSPD-GALRASITHANYSDMELLGGAlgDGIAFKEEGTRDEAGGIVSEVML---
    109 UniRef50_Q1D9F0        Putative general secretion ...    83     2e-14  1  12.0%  44:284 277:522     -------------------------------------------TARTRQQVGAVVltAKLPGIAEQLSRDLNLPVRVLALPaaKAIPAAEQPVAAQAYSLSLRGNAAGVRAPRFNLRRGEFAFKGDFDYMKDKLGLLASFAATLILLLIAFGVVRNSVLARREAQVDAVLCDTTQRILGRCEKDYN------RALNMLAGVESPAAALPRLTalLAEVTGRVPDDMPVKFTRIQIDLSRVILEGETDSSKQIDTLSNAIKNhkDVRQGKvtRDGSKMSFRLDVQ--
    110 UniRef50_A5V9H8        General secretion pathway L...    82     2e-14  1  15.8%   2:260 108:343     -VDRDLMAAWVAHVAEAGIADAAIMPDALALPVPEAgeADGRILVRTPDGAGFAAREALFVALWTAAGKPACDEVEAGGEALPIA----------------------------LDLRQGDYARPRQ--GLSRTGRRVAIVAVAGLVAHGAIAAADTVALRSVAAKRGAELTQLLATAAPGRYAGADPraLVAAELLPAGGNAPPGTLLPLLSRASSALAPFG-GAVTIRSMQFDEAGRSLRLDVDLADPAARGNIVNALR--------------------------
    111 UniRef50_Q2G4Y8        General secretion pathway L...    82     2e-14  1  11.7%   2:284 111:370     -VSAADMDRWIADLSGLGLDPESIIPAGLVLPRDDDR---------------------LVLGTLGGQLLARTPGVAFAGEEALVMTLGAGLEQVLTEEERIAQSLAAIHAAPPLNLRQGAYAAKRVSVFRTADWLGLARMAAIAALLGLLLMLVWIVKWNIDSSALESRALEMAQARFPAATDIDTAERLLNAELARRGQGGASFAAPAA----ALLEAMRAVPAVRLRDLGYAPD-GTLRFTAAAPRADDVNAVLIAlnEGWKVTVPPALAPdgATVAAITVR--
    112 UniRef50_B4WDQ9        General secretion pathway p...    80     9e-14  1  11.3%   2:283 114:368     -VGAGLLEAWIDYLAALGVTPVAVVPDCLILPAPADDALSAAVF-----GTDMGLRGAHFAATVQSDLVEAVAGGRPL--------------IRMDDPETLERLLAAAAAAPAVDLLSG---LERKREVRAGGWRLAAGLAAALVVSPLILTLAVGARDQVAADRAERRTLALITETMPDAARASDP---MEAARRQIAVAPPPGGLASVSAALFAAVEQ--VEGAELDSLSADPGQG-VRATVSYPAFSDLETLRTALAagLSMSDASTVEDGGRVVSEIIV---
    113 UniRef50_A6GLQ1        Putative uncharacterized pr...    79     1e-13  1  12.0%   1:266 121:397     VLGKTRARNIVSSCAQQGLKLAGLSCETL---RERTGSEGAAWLSGQDFILVDGIDTPLLTPTAQAAVLKVMLQRRLQQAGAPVIELNNTdtWLSSQVDGAmrASARAPIEPLPRLLNKSLLNADELRKMGMrlRKLLAPAVALLTVAVVGLNVLAFKIESANASIEAQINESYAQALPNTPMVADPLLLIEREKRNLNAGLDTSNAQGASALLHEvlAMEQAPFNSMVDFAWAENTLSVRFNANVSEDQQGAALQKLKARRLDAK--------------------
    114 UniRef50_C9YDY6        Putative uncharacterized pr...    79     2e-13  1  15.6%   2:206  70:289     -CQRVWLKNTLSALTGAGHTVRRIAPEW----APSTLSDSPTTLWLTGEAEGAELVWavPPSNTSSGTAPAALPTDAAVYAEPACAALAEQLLHREVTVQHRAQRLQSCTDTDWNLAQGEFATRNAALrqAPAWRPARWAFALLCAVQVAGLNAQAWQARQALSSQRSAIQNVLLTTFPNTTVVVDAPLQMQRAVDALGQSSGPGP--------------------------------------------------------------------------------
    115 UniRef50_Q88P00        Type II secretion pathway p...    78     5e-13  1  16.3%   1:270 109:354     VVARQQLDDWRGQCPEWGLQTVRCWAELQLLPSPEPGC-AWQW----QRTPGMSLYKGLAEDGQEHWLA---WPDALGGVPQPPWAVLHRTSLSGNWPTVFA----------PLDTLPGLFDRARKVRSLPAASRQQQRLLAACLVLATVWGGLWLSQQWRQAQLWRSQVIAVTGEQASPRHAAQALKRLRESVLQQQLRTRQLDDLQARLQTWLR-----DNPGLRLQAVRFDGQRWHLRLEGEGSAPPWPD-MAAAAGATVQVQDGQV----------------
    116 UniRef50_Q39Q90        General secretion pathway p...    76     1e-12  1  14.6%  66:284 206:419     -----------------------------------------------------------------RLGAPATAEGTPLPVEGSLAAAFGGDEGAARRYGSAWALATAMAQGDAVDFRAGDLAWTKGKEKALRRLRLPLALAALLLFLLGADASIRYLLVKRDLASLDASIGTIYREVFPGRKKGVDEAAEMRAELRKLGSSGGKSQVLETLNRLAMAKGDDILGLYEVEI-----DSGQVRLKGDARSTQAVNDFKNRLAAMLsaEVGQITSKPDG-TVTFTLR--
    117 UniRef50_Q221L3        Putative uncharacterized pr...    76     1e-12  1  10.3%   1:252 132:393     VCERAWLRAALQVLEQSGRAVSRIVPEFTPQALTNTLYVTGEADAAY-LVGAAEGSVAVLPLSREAMALLAGSEEKNVVAEPAVVASAEALFQRPVTLQQS-ALRQLQAAQSAWDLAQFDLVTSQSARTWKRWAGAARGLLSalLIINLAGLNAWAWKEKSLLNSQRQAIQAVLTTTFPQVRVVVDAPTQMAREVATLQQASGAPSGRD-LESMLGAFGAVAPVNAVPEAIEYVAGEARLklKLTAEQLTAI----------------------------------
    118 UniRef50_Q1GWC6        General secretion pathway L...    74     6e-12  1  10.6%   1:284 115:374     VTTHAAMTGWTGWLAARGLTAAA--------------------IIPAAAALPPPEADSLWSAELGGERIIRSADRAWASDPELDPLIAGNHDVAPLDAEAMREALLLTLAAPPLDLLSGAWKPKRRWAVDPAMLRLAKRLAIALVAVSVAIPIVYALRLTADTSRADDAVVAMATRAGVTASDASAAETEIDRRLATAGGGP--LAFSVPASALYDAM--RDAPGVSLKNLSHRTD-GTLTTTLAAPRVDDINQVLLALQagYRITAQPMAGAGGQQMAHVTIR--
    119 UniRef50_Q6MMP1        Putative type 4 fimbrial bi...    73     1e-11  1  15.3%  76:271 423:632     ---------------------------------------------------------------------------RVSVLDQIPNVNFERSAYHGAVCGVALGLAIEgpRNPPLNFLRGEFAknHQLKMFWEKWGSTIKVATAALVVLFVYSSLRESFALSLADRTQEVLKSQAKTVAGLKGRAAsiRKYIraDLKTLASVANMNSALDIAKKINDAAPPKSSITLDIHQMAIQDAQVTLQGYVNSpeMSLLQQALTNVSTDGQVKSGQST---------------
    120 UniRef50_D0LLX1        Cell division protein FtsA ...    67     7e-10  1  14.0%   3:260 309:557     --EQQRIHGAISrlGSLGREIRRTLQSC----RAKTGATAQYVLLVGGGSRLGGV-----PSFLAETLGLPVERLSSAHAQALFGDKLAGVGAPVDTACVAAGIAFESAgrPHFDLRQGELAYKADLSFLRERAPALLAAAVILLCFATFNGFAALYKLRRAEASLQTELALETTTLFGEPLDVTATMARIGGAAAGKKSVLPRMTAYDILLEVNNKLPAKGDVTLDVQQL--DIRQGKVTFEATARSSPEIDTVEESLQ--------------------------
    121 UniRef50_Q1IB26        Putative type II secretion ...    67     7e-10  1  11.5%  82:263 116:286     ---------------------------------------------------------------------------------AQLVHLQDWLQAGRIRPQGVFTQPAED--RPVVDLGGGLQGPAHSLDVG-----RVVAVWSVAVLVWCLGLNLHAMQLASEGEQLRARMVTQVRTAFPHLPVVLNPLQQTRQQLQSGQGAMGTG----LVALLDGAGKAMPFLAGNVAALDYADGELRITPLAEGRKAPADMAWQTQLAAQG-----------------------
    122 UniRef50_C4K9R3        General secretion pathway p...    65     3e-09  1  13.3%   1:271 108:384     VVARSELATLVATCKALGRPLDAVRSALQLAPPASGEWtgATAVLRTGLQAGMALDAD-STDTLAEWLALQLDATPAEARPTRLEVRSTTGTPIPETPALAARIGVELREGPTlnLLHGEFAPAHGGDGWWRQLRRPALLAAGAAGAWLLVQAALVAIDGGEERALRERGERLAAEALPGQP-LLEPRMQLRRAHERALQVHGQLAAGDLLALLDAALEAGAP---QPQALRYEDGRLTLEL----ASAPPADLLVRLDARGLAARAEGSR---------------
    123 UniRef50_B8JD40        Fimbrial assembly family pr...    65     3e-09  1  15.8% 107:283 351:526     ----------------------------------------------------------------------------------------------------------QGARAPRLNLRRGELAYTRDFEHLKGKLARLGLYAAAILVLAVVSAGVKVFALSRQEAALDRALCDAEQKILGRC----YPNFEEAQAILRGRGTAAAALPRVSAVDVLGELADRVPAEVPVRFDRIEITRDKLHLEGTTDGAESVDKVVEGLRGsgDARSGSARKRASDGKFEFSI---
    124 UniRef50_B4SL36        General secretion pathway L...    64     6e-09  1  12.7%   4:263 114:369     ---QQAIMQAQQLLASCALQLQALYPTPLLLPWQNGQadGEHLLVRCGRDRGVVqdVGAVLQSLAARLQQSGVQAVQWIDSVPSVWPESLPATVVAHELQACGPLPAWSLPLPGRSRQAP--------------RLAVGLAVAALVLAALGLQLQVSRWRSEGEALQQDMARQFSARFPEITDVVDPVLQARRALAVPLPAPPLPPVQRQVATTLQAVPEL---GGQVRGLHYTPGQLELELdiLADDAQRLEQWQQAVQAQG-----------------------
    125 UniRef50_C4XH40        Putative uncharacterized pr...    63     1e-08  1  12.9%  29:284 198:476     ----------------------------LPLPEAADAAQQATFLAREAVLTLSALASQPPVGLNLILGGKVDRPQAAAALEAALGVPATSLSALPGWPRLPTGEALPEALALAynFLRGELAPAASRATLRRALLLAGGSALVLAVCAIGAYFSMLWRLDASLTRTRAETEAVIAAAAPDLAPSLTLPQKLsaATRRDQGTGPVGGVLEILAAIHQGLGPDGAAKARRVAL----DESRATIDAVADDYTTVDAVKRRLAagVEIRGAKNNPEKKQVEFQLDLK--
    126 UniRef50_A9IRQ2        GspL protein n=1 Tax=Bordet...    61     3e-08  1  12.0%  59:242 120:297     ----------------------------------------------------------ARDALRAAWRRLSSAGLAVQAFYPLQVWSETPEQARPAALDDIRDP-RWRAPGPGWSLALPQLAPRQPSR-----WRGAWAWLAAAAAVWIAGLNLYAAQLRHEATRLRERMEQDVRDALPDIPVVLDPVRQARQARDALRAGQGEAAGNDLLSLARVAVQVLPFAADTVDRLEYGDGILTLRL--------------------------------------------
    127 UniRef50_A3SDU1        Putative uncharacterized pr...    60     7e-08  1  14.6%  25:285  95:344     ------------------------LPEYLLIPRPPSDneGNRAVVRCSDGTGFAANVNMLPLLWQRAGR------------PSLRALGEPLGADLPAENLSATPPPPDPIDVAFSFAQ----PRKAAARGLAAWKWAAVAVGSALALHMTIAALNLRALSQIAQTERRAAELAISDILPGMALTREVGPVLAR-LTPAQAVVKESSFLPLLSDISRVLTDAPVG---FRRMAWGASENTLVVLMQSPGLDDLQGIEQTLEagFAVRSGAATAGDGGAEVEMRIAR-
    128 UniRef50_UPI00016990A8 hypothetical protein Epers_...    60     1e-07  1  17.3% 110:190    1:81     -------------------------------------------------------------------------------------------------------------PRSLLNLLQDEYRHVDAGVQLLKPWISAAVLLMVFLTLQVTLSVLDFIKIDQENSQLSQQIRQLFHSTFPETKWLVDAKAQ------------------------------------------------------------------------------------------------
    129 UniRef50_C4UIB0        General secretion pathway p...    59     1e-07  1  21.1%    2:58 101:161     -INKDVIKYWLRWFYELDINPDFVIPDVLCLPYLKDQWSagNLLVRTGKCSGFSIDKE------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
    130 UniRef50_Q3BXL8        Type II secretion system pr...    58     3e-07  1  13.5%   2:283 105:358     -VDSVVMQHWLARATQLGFVPDAVVPDCLLLEPGADATVagRWLIR-GAQLACSLEPEAARLLLGDRVPAVP---------------------PVPDPTQSIACFARNAAHVPIDLLQHPFANKAAAEQRRAP-RRLAVLAALLLLSPGVLLLAQTLRYEIGARVLQACAATQL--------GVRDAAAVPAALQARRQAGTATDRLAVQLSTLFGAVD--TLPAAELDQLDYNAAQP-LRATLLHTDDASLQQLSARLaaGWHVDPGSSQVEDGRMRTPLAL---
    131 UniRef50_UPI00016990A7 hypothetical protein Epers_...    53     2e-05  1  17.0% 192:285    7:99     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------EQKLKELRTTQSTNQADFFSLFIAPASAIKESRGSKLRGISYRD--GQLDIQLSTREIQAIEALKKRLeeGLAVEIRSANAKGNEVTSHLRITR-
    132 UniRef50_A6BC52        General secretion pathway p...    52     2e-05  1  17.2%    2:59   13:74     -VERAWVQTVLQRFASQGLTIKRILPDVLALPVSDdaLIGEQWLIRHSETEGAVVDSAW-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
    133 UniRef50_Q2KZM9        Putative general secretion ...    49     3e-04  1   8.0%  57:269 104:312     --------------------------------------------------------DGQVEVAWTPRPALEQACALLAGQGMRLRAIIPPSALGEGQALQARGDPRWRAPSPGWSL-----ELPRQAGNTVSQWRSPLQWAAAAALLWLIGLNLYASHLEAEARALRARMTQRVQQSF-NLPVVLDPLRQAQQGLAALGSGQANSH--DFLSLARDVARLPLPTDDRVKQLNYADQALTLQLFAEEDAARQVAviQQAASLGLKLEQQE-----------------
    134 UniRef50_C6HW28        Putative uncharacterized pr...    68     5e-10  1  15.2%   3:284 141:464     --SQEEVARLLTRIEESGLSPRWILPESlpLPVGPERQTAGmcQIREGGPGGSDidRRILDLLLSLAATDLSLPPRFAIDSplPESPLAPLVAQVPPVTRPLGEAasGEELASLTFRKGPLAWQGDRAEIRKGIRSLALLSLVLAGVLVADGSAHLSRMNHRVERAREALDREARMALPGH-AIVMPVEQLTQEKAALDRQRHLLSRGADIIGLMKAITAAPPPGVKVELVSLSISRRFVTLSGKTGSFRNVDAFKSSLAATGLIRDISIQSAgdRKTVTFRMR--
    135 UniRef50_Q9RW98        Putative uncharacterized pr...    43     0.013  1  14.3% 114:204    4:89     -----------------------------------------------------------------------------------------------------------------INLLPKEYRRQSQPSVWKYASWAAAGLTAAVLGGWFLSVSGDTNQLRERSAALQQQIDAVA----PQKSRFNDLTAQ-QGELERVTQVATQ----------------------------------------------------------------------------------
        consensus/100%                                                                                      ..............................................................................................................................................................................................................................................................................................
        consensus/90%                                                                                       ..................................................................................................................shht...............hh..hhhhhhhhhh.hh...h.........t.htt...t.h.t.h............ht..ht.................h................h.h..t...h.h............................................
        consensus/80%                                                                                       .............h.........hh.t....s.......t..hhh......s..h....h...h..............................................t..hshhpt.ht.t...t..h..ht..hhhhhhhhhh.hh...h.h..httt.tthptt..t.htphhst...h.s...thttthtthttt.t..th...ht.h..hh.......hth.thphp.t...lphth...t.t.htth.t.htt.h.h....................
        consensus/70%                                                                                       ..ttt.ht.hht.htthsht.t.hhs-hhhlP...tt..ttphhht.s..tuh.h..thh..hhtt..........h...t.......t..th.........t.hhtth.ts.hsLhpu.at.ttthtt.ht.hphshhhsshhhhh.hh.hhhthhthppptpthptthtthhpphhPt.thhhs..hphpttltphttststsshh.hht.httsht.....thphptlpapttp.plphphts.shtthpthttthttth.hp.t..t...t.........

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown